In 2015 and 2016, Zika virus (ZIKV) swept through many Latin American countries where dengue virus (DENV) is endemic. Dengue and Zika viruses are of the same family, share a vector and may interact competitively or synergistically through human immune responses. We examine dengue incidence data from Brazil and Colombia from before, during, and after the Zika epidemic. We find evidence that dengue incidence was atypically low in 2017 in both Brazil and Colombia. We investigate whether Zika incidence at the state or department level is associated with changes in dengue incidence and find mixed results. We use simulations to investigate expected impact of cross-protection or enhancement between dengue and Zika. Our simulations show that regardless of the mechanism, low periods of dengue incidence are followed by a resurgence in dengue cases. It is therefore likely that countries currently experiencing low levels of dengue incidence will experience large dengue seasons in the near future. By considering multiple combinations of DENV and ZIKV reproduction numbers, we demonstrate that the mixed results of our statistical models are not entirely unexpected. Correlations in DENV and ZIKV reproduction number could contribute to complicating or masking an association between their case counts.
had the lowest annual incidence rate (IR) of dengue since 2005 ( Fig. 1a) and Colombia had the lowest annual dengue incidence since 2007 (the first year of available data) ( Fig. 1c ).
Departures from expected dengue incidence. We quantified the probability of departures arising by chance from expected dengue incidence using time series models with seasonal variation in autocorrelative effects (see Methods, Supplementary Fig. 2, 3 ). Biweeks with atypically large incidence occurred significantly more often than expected in Brazil in 2015 ( Fig.   2a, 2b) . In 2017, Brazil experienced an increase in both atypically high and atypically low biweeks compared to expectation. In Colombia, a significant increase in atypically low biweeks was observed in 2016 and 2017 ( Fig. 2c, 2d ) (see Methods and Supplementary Fig. 4 , 5 for further details).
Hierarchical models characterize departures in expected dengue incidence. To attempt to explain the significant departures that we saw in each location, we built a set of hierarchical time series models that incorporated a number of subnational covariates. These models forecasted dengue incidence using combinations of seasonal dengue terms, year effects, and recent incidence of Zika. For a baseline, we also fit models incorporating chikungunya incidence.
CHIKV shares climate and vector determinants as DENV and ZIKV but is of a different viral family and thus is not expected to interact immunologically with flaviviruses.
In models incorporating year effects, we found that biweekly expected dengue incidence in 2015 was higher than that of corresponding biweeks in other years in both Brazil (mean: 2.21fold increase, 95% CrI: 1.45 to 3.37) and Colombia (mean: 1.11-fold increase, 95% CrI: 0.96 to 1.29) . In contrast, we found that biweekly dengue incidence in 2017 was lower in both Brazil (relative incidence mean: 0.63, 95% CrI: 0.46 to 0.86) and Colombia (relative incidence mean: 0.23, 95% CrI: 0.18 to 0.29). At the subnational-level there are differences in the significance and direction of these effects (Fig. 3b, 3d) , with the exception of 2017 in Colombia, where there is a significant reduction in biweekly dengue incidence in all departments (Fig. 3d ).
We found a positive association between the previous biweek's Zika incidence and dengue transmission potential in Brazil (mean coefficient: 0.16, 95% CrI: 0.05 to 0.26, Fig. 3a ).
Putting this coefficient in context, 1000 Zika cases observed in the previous biweek translates to a multiplicative increase of about 3 times as many expected dengue cases in the following biweek (mean: 2.92, 95% CrI: 1.40 to 6.15) . We also found a positive association between cumulative Zika incidence on dengue transmission potential in Brazil (mean coefficient: 0.04, 95% CrI: 0.003, 0.08). No significant association were found between Zika incidence and dengue transmission potential in Colombia.
In Brazil, cumulative (mean coefficient: 0.04, 95% CrI: 0.01 to 0.08, Fig. 3a ) and biweekly (mean coefficient: 0.11, 95% CrI: 0.04 to 0.17, Fig. 3a ) chikungunya incidence were positively associated with expected dengue transmission in the following biweek ( Fig. 3a, 3c , Supplementary Fig. 6 ). No significant association were found between chikungunya incidence and dengue transmission potential in Colombia.
In Brazil, states with positive effects of Zika on dengue transmission potential often observed positive effects of chikungunya on dengue ( Supplementary Fig. 6 ). Totals of suspected Zika and suspected chikungunya cases at state-and department-level were positively correlated ( Supplementary Fig. 7 ), consistent with potentially shared environmental suitability conditions for transmission of these viruses.
We tested whether the direction of country-level effects was an artifact of our model implementation, by replacing 2015 to 2017 with a random three consecutive years of data preceding 2015 and then repeating the model fitting procedure. We did not find agreement in the directionality of the country-level effects across the resulting models (see Supplementary   Fig. 8 ), supporting our main results. In 2017, low dengue incidence rates ( Fig. 1 ), atypically high numbers of biweeks with lower than expected dengue incidence (Fig. 2 ), and negative country-level effects ( Fig. 3a and 3c) indicate a reduction in dengue incidence in Brazil and Colombia. Utilizing available Zika case data, we were unable to establish a direct link between this reduction and the Zika epidemic. It is important to note that there are limitations to using passive surveillance data (as we have done here), particularly when novel pathogens are involved. In the case of ZIKV invasion in the Americas, many cases that occurred early in the epidemic were not reported, since it took time to first identify the presence of ZIKV and then to establish reporting protocols.
The unavailability of Zika case count data during the height of the ZIKV epidemic in northeast Brazil, one of the most severely affected regions 33 , may have contributed to our inability to identify a relationship between cumulative Zika cases and observed dengue incidence. In both Brazil and Colombia, misclassified cases (potentially resulting from shared symptoms between case definitions of dengue, Zika, and chikungunya) also may have restricted our ability to detect such a relationship. Other factors such as climatological effects 12 or additional mosquito control efforts 1, 11 and avoidance behavior may have played a role in reducing dengue incidence.
Stochastic simulations incorporating immune-mediated interactions.
We tested whether immune-mediated interactions between DENV and ZIKV could produce the dengue dynamics observed in Brazil and Colombia by simulating the arrival of Zika in a dengue endemic population ( Fig. 4 ). We used a stochastic compartmental model that incorporated combinations of cross-protection or enhancement between the two viruses. In simulations where ZIKV infection temporarily reduces an individual's risk of DENV infection, Zika epidemics are followed by a trough in dengue incidence ranging from 2.2 years to 3.4 years depending on the scenario ( Fig. 4 ). Multiple simulations showed increases in dengue after troughs ranging from a 1.2-fold increase to a 2.5-fold increase ( Fig. 4 ). Based on our simulations, which assumed that crossprotection lasts one year on average, the time until dengue resurgence (trough duration) would likely be longer than the assumed one-year duration of cross-protection. In all scenarios, suppression of DENV transmission resulted in subsequent increases in DENV prevalence, suggesting that the low period of incidence observed in 2017 may be followed by large increases in DENV.
We also tested the impact of correlation in ZIKV and DENV transmission intensity on observed associations between cumulative ZIKV and DENV incidence (see Supplementary Fig.   9 ). We consistently observed a reduced impact of ZIKV on dengue in simulations where DENV transmissibility was assumed to be higher. When the transmissibility of ZIKV and DENV were assumed to be equal, reductions in DENV due to cross protection were not larger in simulations with higher ZIKV attack rates as the impact of ZIKV was offset by increased DENV transmissibility. These results are consistent with an unclear or variable relationship between DENV reductions and cumulative ZIKV incidence as we have observed in the data.
Our results demonstrate a significant decline in dengue cases in 2017 in Brazil and Colombia. Studies involving laboratory confirmed cases and enhanced serosurveillance (see for example Ribeiro et al. 2018 33 ) will play an important role in pinpointing the mechanism underlying this reduction. Our simulation results show that troughs in dengue incidence are followed by atypically high dengue levels. Atypically low dengue case counts observed recently in Brazil and Colombia suggest that population-level susceptibility to symptomatic dengue has been building. Such high levels of susceptibility could fuel large dengue epidemics in upcoming seasons.
Figure 1:
Estimated dengue incidence in Brazil and Colombia (per 100,000). States are arranged by region and then by latitude from North to South. Note that Zika incidence was not systematically reported prior to 2016 in Brazil (a) or late 2015 in Colombia (c) and that Chikungunya was not systematically reported prior to 2015 and late 2014 respectively in Brazil (a) and Colombia (c). In Brazil, updated data from the following year's bulletin for 2014 to Epiweek 42, 2017 is used.
Figure 2:
Comparison between predicted and observed dengue incidence. Results for 2014-2017 are shown for Brazil (a, b) and Colombia (c, d) (see Supplementary Fig. 4 , 5 for full time series). b, d Red or blue indicate that the observed incidence fell above or below the median of 500 draws from the posterior of predicted values for that biweek. Medium or dark shading indicates that the observed incidence fell outside of the 90% or 95% prediction interval (PI) for that biweek. a, c The number of biweeks with observations falling below (blue) or above (red) the 90% PI are displayed with a quantile of the observed number of significant biweeks out of a distribution generated by 10,000 bootstrapped replicates. In these replicates, year labels were randomly re-assigned for each location before counting the biweeks in each year that were above or below the 90% PI (see Methods for further details).
Figure 3:
Spatial hierarchical biweekly dengue incidence models. Shared coefficients from the year model are highlighted in yellow. Mean and 95% credible intervals (CrI) for the shared effect coefficients for Brazil (a) and Colombia (c). Zika and chikungunya coefficients are estimated from autoregressive dengue models. Positive (negative) coefficients indicate increases (decreases) in expected dengue incidence for the year model and indirectly as effects on transmission for the Zika and chikungunya models. Mean and 95% CrI for the year multiplier on expected dengue incidence for Brazil (b) and Colombia (d). Shared multipliers in the top row of panels b and d are translated from coefficients in panels a and c. Other rows display subnational effects (combined shared and location specific effects).
Figure 4:
Simulation results incorporating immune-mediated interactions between DENV and ZIKV. Mean and 95% inter-quantile range from stochastic simulations spanning 10 years post ZIKV-introduction. 100 simulations per scenario. ZIKV introduced after a 100 year burn-in period for four DENV serotypes. a-d Individuals with previous dengue exposure experience 20% of the DENV force of infection (FOI) that a fully susceptible person would. e-h Individuals with previous ZIKV exposure experience 80% of the FOI that a fully susceptible person would. i-l Individuals with ZIKV exposure experience 20% of the DENV FOI (same amount of cross-protection between dengue and Zika than between dengue serotypes).
Methods
Data sources. We collated data from Brazil (27 states) and Colombia (32 departments) into a public data repository 13 . For Brazil, monthly dengue data is available for some states starting in 1986 from the National Health Foundation-FUNASA and for all 27 states starting in 1999. We Data entry accuracy was checked by re-entering 10% of the weekly bulletins. Within these bulletins, we found that less than 0.01% of the numeric fields entered were inconsistent between the primary and secondary entries.
The Epidemiological Bulletins published in Brazil for 2014-2017 also report the corresponding dengue data for the previous year. We use the available previous year data reported in the 2014-2018 bulletins to obtain probable dengue case counts for 2013-2017
Epiweek 42 since these data are most comparable to the preceding historical data. Analogous updated probable Zika and chikungunya case counts were first reported in 2017 and 2016 respectively. We use these updated counts in our analyses. We also use data on the cumulative number of microcephaly cases and other central nervous system disorders in newborns 34 reported in Brazil since Epiweek 45, 2015 through the end of 2016. Cumulative number of cases later disregarded from the system was also reported. We therefore deduct the disregarded counts from the case counts.
For Colombia, we use weekly department-level probable dengue case count data from the Colombian Instituto Nacional de Salud (INS) website 16 . This dataset includes weekly dengue case counts for 2007-2017, with severe dengue cases reported separately for 2014-2017. We excluded cases with an unknown department and those that were considered imported from other countries. When combined counts for districts with the counts for the department in which they are located, whenever they were reported separately. We extracted additional data for To avoid negative biweekly incidence values, we constructed strictly nondecreasing upper, middle, and lower approximations of the cumulative time series. Working backward from the most recent time point, we accounted for decreases in the cumulative count by either subtracting the difference from all previous time points (lower approximation) or by setting the higher incidence equal to the lower incidence in the following biweek (upper approximation).
This process was repeated for all time points, resulting in a strictly nondecreasing time series.
The middle approximation is constructed by averaging the values of the upper and lower approximation at each time point.
To determine which approximation to use in our analyses, we calculated the sum of For each location and disease, we fit a spline to the adjusted cumulative incidence curve by using the smooth.spline function from the stats package in R. A knot was assigned to each data point. We used a binning procedure to translate the continuous spline into a biweekly sequence of predicted case counts. Cases were assigned to biweeks with probabilities based on the difference in predicted case counts at endpoints of consecutive biweeks. When consecutive predicted spline values decreased, the probability of assigning cases to the first biweek was set to zero. We repeated the reassignment process 1000 times to create 1000 case count time-series and then calculated the mean incidence for each biweek (averaged over the 1000 simulations), rounded down to the nearest integer to obtain the final biweekly case count.
In what follows, we refer to this value as the "observed incidence".
Seasonality evaluation. For each dengue season, we identified the biweeks with the three greatest numbers of cases in each subnational location (states in Brazil and departments in Colombia). In Brazil, dengue seasons were defined to range from biweek 18 to biweek 17 of the next year, to avoid splitting the season into multiple years. In Colombia, there was not a clear start and end of a dengue season, so we did not define a particular season that spans across multiple calendar years. See Supplementary Fig. 1 which describes the seasonality for states and regions.
Time series models.
For each year of available data, we fit a one-step autoregressive model with negative binomial errors for each state in Brazil and each department in Colombia using incidence data from that location in all other years. For each the location, the number of dengue cases in the following biweek is modeled as follows:
, +1 ~ ( , , ) log , = 0 + log( , + 1) + log where 0 is an intercept, is a multiplicative factor scaling transmission for biweek in biweek category ∈ {1, … , 26}, , is the number of probable dengue cases in biweek , is the population size (specific to the year and location), and is the dispersion parameter. We did not fit a separate model for Vaupés, Colombia, since there are no probable dengue case counts reported for this department in 2007, 2008, 2009, 2011, and 2015. We also did not fit any regression models for the capital of Colombia, Bogotá, since there is limited corresponding dengue incidence and these cases are considered to originate from other departments. Fitting procedure and model performance. We fit all time series models using the rstanarm R package 37 by implementing Bayesian MCMC methods. For each model, we sampled four chains with 10,000 iterations each (5,000 iterations included as warmup) for subnational level models and 10,000 iterations each for national models. Convergence was evaluated by using the launch_shinystan function of the rstanarm R package 37 . We primarily assessed the convergence of our models using the Gelman-Rubin convergence statistic 38 and deemed convergence adequate when R is less than 1.1. We also checked to see whether there were any parameters with an effective sample size less than 10% of the total sample size or any parameters with a Monte Carlo standard error greater than 10% of the posterior standard deviation. We noted whether there were any divergent transitions after the warmup period. We evaluated model performance by calculating R 2 values for the focal year of predictions (out-ofsample values) and predictions of the data used to fit the models (in-sample values) (see Supplementary Fig. 3 ).
Comparisons between predicted and observed dengue incidence. Starting with the second
biweek of data for a given location, we sampled 500 values from the posterior distribution for predicted incidence for the corresponding model (fit using data from all other years). We then evaluated the quantile of the observed incidence in that biweek in the cumulative distribution of posterior predicted values. We consider the observed state-or department-level incidence in a particular biweek to be statistically atypical if it falls outside of the 90% prediction interval (PI),
i.e. if the observed quantile is less than 0.05 or greater than 0.95 (see Fig. 2 and Supplementary   Fig. 4 ). We repeated this analysis using a Bonferroni adjusted quantile ( Supplementary Fig. 5 ).
Further, we implemented a permutation test to consider whether the number of atypically high or low observed incidence values in each year (separately for each country) was significant. For each location, we reassigned the years (sampling without replacement). Then for each year we counted the number of statistically high or low values of observed incidence. We repeated this procedure 10,000 times and then found the quantile of the observed numbers of atypically high or low biweeks within the cumulative distribution function generated from the permuted data (see Fig. 2a and 2c ). This permutation procedure preserves temporal correlation within the years. We considered a second permutation test that preserved spatial correlation within each biweek. For this test, we reassigned biweek labels. For each biweek, we sampled without replacement from the years of available predictions for the corresponding biweek category (ranging from 1-26). We then reassigned the quantiles of that particular biweek to be the corresponding incidence from that biweek category in the resampled year. Again, we performed 10,000 permutations and found the quantile of the observed counts of statistically high or low biweeks in the corresponding cumulative distribution function. Results were similar between the two permutation tests. Between the two tests, quantile differences for each year were less than 5% (median value 0.012, n=58) and significant results (q>95%) presented in Figure 2 were maintained. Note that we did not include 1999 in the permutation test for Brazil since data is not available for the entire year in Acre (the first dengue case in the dataset is in August 1999).
Hierarchical regression models.
Separately for Brazil and Colombia, we fit a set of spatial hierarchical models for dengue incidence (using state-level data for Brazil models and department-level data for Colombia models) with negative binomial errors. We considered models with either a log-additive effect for recent years (2015, 2016, 2017) or a multiplicative effect of either Zika or chikungunya case counts (previous biweek or total count recorded up to and including the previous biweek) on expected dengue cases. We focus on an absolute incidence version of the year effect model, where a dengue seasonality (biweek) indicator is used instead of the log-dengue case count predictor used in the other models. The subnational location-specific effects account for deviation from the country-level shared effects. During the fitting procedure, a variance term is also fit for the distribution of location-specific effects. These models take the following form:
, , +1 ~ ( , , , )
Additive model: We ran 100 simulations for each scenario using a tau-leap approximation of the Gillespie method in Fortran. ZIKV was introduced into the mosquito population after 100 years of DENV only simulations with randomized initial conditions. An additional 20 years of data was simulated after the introduction of ZIKV. We considered DENV and ZIKV reproduction numbers for all combinations of 2 and 4, and for the case when both are set to 3 (see Supplementary Fig. 9 ).
The human population size was 10 million and the mosquito population size was 20 million.
Simulation data analysis was performed in MATLAB and R.
To evaluate the effects of incorporating cross-protection or enhancement, we consider changes in trough duration and peak size. All scenarios that incorporated an immune-mediated interaction were evaluated against the baseline determined by the scenario with no enhancement and no cross-protection between DENV and ZIKV. We define the trough duration to be the length of time that aggregated DENV prevalence is consecutively less than on half of the average incidence following the introduction of ZIKV, in the baseline scenario (approximately 16 individuals per 100,000 population). We set the trough duration to zero for all simulations that did not include a complete trough within the 20 years following the introduction of ZIKV. Peak size is defined to be the maximum dengue prevalence value, aggregated across all serotypes, in the 20 years following the introduction of ZIKV. Changes in peak size resulting from incorporating an immune-mediated interaction were evaluated by dividing the average peak size by the average peak size in the baseline case (where the average is taken across the 100 simulations of each scenario). 
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